Lobbying activity
Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 729 filings
Top spenders & firms Spend by issue Political contributions Revolving door
Q2
BROYDRICK & ASSOCIATES for TONIX PHARMACEUTICALS
Q2
CROSSROADS STRATEGIES, LLC for ALKERMES, INC.
Q2
UCB, INC. for UCB, INC.
Q2
OREGON HEALTH & SCIENCE UNIVERSITY for OREGON HEALTH & SCIENCE UNIVERSITY
Q2
ARNOLD & PORTER KAYE SCHOLER LLP for NOVO NORDISK, INC.
Q2
ARNOLD & PORTER KAYE SCHOLER LLP for GENETIX BIOTHERAPEUTICS, INC.
Q2
ECOLAB INC. for ECOLAB INC
Q2
NORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
Q2
DA VINCI GROUP for PROCARE, INC.
Q2
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Q2
DA VINCI GROUP for BOESEN & SNOW, LLC
Q2
HOLLAND & KNIGHT LLP for ECOLAB, INC.
Q2
VENABLE LLP for STRIVE SPECIALTIES, INC.
Q2
UNITE HERE! for UNITE HERE!
Q2
CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. for CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC.
Q2
HANCE SCARBOROUGH for BOEHRINGER INGELHEIM USA CORPORATION
Q2
MEHLMAN CONSULTING, INC. for WEDGEWOOD PHARMACY LLC
Q2
HANCE SCARBOROUGH for ALLIANCE FOR PHARMACY COMPOUNDING
Q2
MEHLMAN CONSULTING, INC. for BETTER LIFE HEALTH, INC.
Q2
EMERGENT STRATEGIES for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Q2
EMERGENT STRATEGIES for GENBIOPRO, INC.
Q2
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
Q2
DLA PIPER LLP (US) for XEROX HOLDINGS CORPORATION
Q2
AMERICAN VETERINARY MEDICAL ASSOCIATION for AMERICAN VETERINARY MEDICAL ASSOCIATION
Q2
P STREET PROJECT, INC. for P STREET PROJECT, INC.